Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial (Q34170485)

From Wikidata

Jump to navigation Jump to search

scientific article

edit

Language	Label	Description	Also known as
English	Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial	scientific article

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

title

Exploratory analysis of the effect of intravitreal ranibizumab or triamcinolone on worsening of diabetic retinopathy in a randomized clinical trial (English)

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

main subject

diabetic retinopathy

1 reference

based on heuristic

inferred from title

author

Diabetic Retinopathy Clinical Research Network

series ordinal

9

object named as

Diabetic Retinopathy Clinical Research Network

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

David G. Miller

series ordinal

8

object named as

David G Miller

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Susan B Bressler

series ordinal

1

object named as

Susan B Bressler

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Neil M. Bressler

series ordinal

4

object named as

Neil M Bressler

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Roy W. Beck

series ordinal

5

object named as

Roy W Beck

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

author name string

Haijing Qin

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Michele Melia

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Clement K Chan

series ordinal

6

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

Sandeep Grover

series ordinal

7

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

language of work or name

English

0 references

publication date

1 August 2013

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

published in

JAMA Ophthalmology

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

volume

131

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

issue

8

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

page(s)

1033-1040

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

cites work

Long-term effects of ranibizumab on diabetic retinopathy severity and progression

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Ranibizumab for diabetic macular edema: results from 2 phase III randomized trials: RISE and RIDE.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Randomized trial evaluating short-term effects of intravitreal ranibizumab or triamcinolone acetonide on macular edema after focal/grid laser for diabetic macular edema in eyes also receiving panretinal photocoagulation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Randomized trial evaluating ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Exploratory analysis of diabetic retinopathy progression through 3 years in a randomized clinical trial that compares intravitreal triamcinolone acetonide with focal/grid photocoagulation

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Intravitreal injection of bevacizumab (Avastin) as adjunctive treatment of proliferative diabetic retinopathy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

5 July 2018

Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

28 October 2018

Intravitreal bevacizumab (Avastin) for neovascular age-related macular degeneration

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

28 October 2018

Changes in retinal neovascularization after pegaptanib (Macugen) therapy in diabetic individuals

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

28 October 2018

A computerized method of visual acuity testing: adaptation of the early treatment of diabetic retinopathy study testing protocol

1 reference

stated in

PubMed Central

reference URL

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4162127

retrieved

28 October 2018

Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23807371

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Fundus photographic risk factors for progression of diabetic retinopathy. ETDRS report number 12. Early Treatment Diabetic Retinopathy Study Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23807371

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23807371

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. The Diabetic Retinopathy Study Research Group

1 reference

stated in

PubMed

reference URL

https://pubmed.ncbi.nlm.nih.gov/23807371

retrieved

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

DOI

10.1001/JAMAOPHTHALMOL.2013.4154

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

PMC publication ID

4162127

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

PubMed publication ID

23807371

1 reference

stated in

Europe PubMed Central

PubMed publication ID

23807371

retrieved

31 July 2017

 

Sitelinks

Wikipedia(0 entries)

edit

Wikibooks(0 entries)

edit

Wikinews(0 entries)

edit

Wikiquote(0 entries)

edit

Wikisource(0 entries)

edit

Wikiversity(0 entries)

edit

Wikivoyage(0 entries)

edit

Wiktionary(0 entries)

edit

Multilingual sites(0 entries)

edit

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34170485&oldid=2050979133"